FundedIQ
Health Care

OncoLize: Funding, Investors & Team (Sep 2026)

OncoLize provides an advanced solution for injectable drug reservoirs that can enhance the efficacy of tumor therapy.

oncolize.com LinkedIn Maastricht, Netherlands 1-10 employees
Medical Pharmaceutical Injectable drug depots Biomedical polymers Pharmaceutical hydrogels Oncology Glioblastoma multiforma Drug delivery
Total raised
$1.7M
Rounds
1
Latest
Seed
Apr 2023

OncoLize has raised $1.7M across 1 funding round on record, the most recent a Seed of $1.7M announced in Apr 2023.

That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

OncoLize Company Profile and Key Stats

Total funding raised
$1.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.7M in Apr 2023
Employees
1-10
reported band
Headquarters
Maastricht, Netherlands

Latest funding round on record: Apr 2023.

OncoLize Funding Rounds

Date
Round
Amount
Seed
$1.7M

OncoLize Founders and Leadership Team

Name
Role
Contact
Prof Helena Kelly
Founder

No contact details are on record for this team yet.

OncoLize Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
740
$5.0M
16,485
$3.1M

OncoLize's latest round of $1.7M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like OncoLize in Health Care and Maastricht

Companies Similar to OncoLize

The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis.…

Undisclosed round $23.3M

Vitestro revolutionizes the way patients are cared for by introducing independent blood-drawing technology.

Series B $70.0M

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and…

Series D $13.0M

Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have…

Undisclosed round $410k

CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left…

Undisclosed round $10.8M

Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in…

Series A $7.1M

Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a…

Undisclosed round $5.0M

Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current…

Pre-Seed $1.4M

AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines…

Pre-Seed $380k
Seed $1.1M

Sirius medical helps in improving healthcare for cancer patients by developing medical devices that helps in…

Undisclosed round $10.3M

PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health…

Undisclosed round $2.5M

OncoLize Funding FAQs

What does OncoLize do?

OncoLize provides an advanced solution for injectable drug reservoirs that can enhance the efficacy of tumor therapy.

How much funding has OncoLize raised?

OncoLize has raised $1.7M across 1 round on record. The most recent is a Seed of $1.7M announced in Apr 2023.

When did OncoLize last raise funding?

OncoLize's most recent funding round on record is a Seed of $1.7M, announced in Apr 2023.

Who founded OncoLize?

FundedIQ lists Prof Helena Kelly (Founder) at OncoLize.

Where is OncoLize headquartered?

OncoLize is based in Maastricht, Limburg, Netherlands.

How many employees does OncoLize have?

OncoLize is in the 1-10 employee band.

How does OncoLize's funding compare to other Health Care startups?

OncoLize's latest round of $1.7M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's OncoLize Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OncoLize is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.